32 家公司符合这项检验
数据截至 2026年11月15日
| # | 公司 | 评级 | 市值 | 净利率 | 资本回报率 | 营收增长 |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY AND COMPANY | A+ | US$1.36T | 31.9% | — | 每年 +39% |
| 2 | JNJJohnson & Johnson | A+ | US$687.9B | 16.2% | 12.0% | 每年 +6% |
| 3 | TMOTHERMO FISHER SCIENTIFIC INC. | A+ | US$259.4B | 14.9% | 7.6% | 每年 +3% |
| 4 | AMGNAmgen Inc. | A+ | US$251.9B | 24.1% | 12.5% | 每年 +13% |
| 5 | ISRGIntuitive Surgical, Inc. | A+ | US$153.8B | 25.5% | 14.3% | 每年 +19% |
| 6 | MDTMedtronic plc | A+ | US$131.6B | 13.9% | 6.6% | 每年 +6% |
| 7 | SYKSTRYKER CORP | A+ | US$117.9B | 13.8% | 9.3% | 每年 +10% |
| 8 | GSKGSK plc | A+ | US$108.9B | 17.5% | 19.0% | 每年 +4% |
| 9 | EWEDWARDS LIFESCIENCES CORPORATION | A+ | US$61.6B | 15.3% | 9.4% | 每年 +17% |
| 10 | IDXXIDEXX LABORATORIES INC /DE | A+ | US$55.5B | 25.4% | 50.9% | 每年 +9% |
| 11 | VEEVVeeva Systems Inc. | A+ | US$48.8B | 29.3% | 9.8% | — |
| 12 | ONCBEONE MEDICINES LTD. | A+ | US$47.6B | 13.9% | 7.2% | 每年 +44% |
| 13 | ILMNIllumina, Inc. | A+ | US$31.3B | 19.7% | 13.4% | 每年 +1% |
| 14 | THCTENET HEALTHCARE CORP | A+ | US$22.8B | 17.2% | 16.5% | 每年 +3% |
| 15 | NBIXNEUROCRINE BIOSCIENCES, INC. | A+ | US$16.9B | 19.0% | 12.5% | 每年 +28% |
| 16 | EXELEXELIXIS, INC. | A+ | US$16.8B | 35.5% | 31.3% | 每年 +12% |
| 17 | EHCEncompass Health Corporation | A+ | US$13.8B | 10.2% | 7.6% | 每年 +11% |
| 18 | TECHBIO-TECHNE Corp | A+ | US$11.4B | 14.0% | 7.8% | 每年 +2% |
| 19 | HALOHALOZYME THERAPEUTICS, INC. | A+ | US$11.4B | 26.9% | 16.1% | 每年 +32% |
| 20 | TGTXTG THERAPEUTICS, INC. | A+ | US$9.8B | 11.8% | 10.8% | — |
| 21 | HNGEHinge Health, Inc. | A+ | US$9.4B | 21.0% | -290.9% | 每年 +40% |
| 22 | KRYSKrystal Biotech, Inc. | A+ | US$9B | 47.9% | 10.4% | — |
| 23 | HQYHEALTHEQUITY, INC. | A+ | US$8.6B | 17.4% | 8.2% | 每年 +13% |
| 24 | PTGXPROTAGONIST THERAPEUTICS, INC. | A+ | US$8.5B | 62.0% | -25.2% | — |
| 25 | KNSAKiniksa Pharmaceuticals International, plc | A+ | US$8.2B | 11.6% | 10.5% | — |
更多排行榜
排行榜按一个明确说明的指标给公司排序。它不是推荐,也不说明任何股价是否合理。